Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Medicine, 2025
Revealing the causal association among clonal hematopoiesis (CH), stroke and circulating inflammatory factors: A Mendelian randomization study

Yu H., Zhang G., Li W. et al.

Olink Target 96NeurologyPathophysiologyPlasma

European Journal of Preventive Cardiology, 2025
Aortic stenosis risk and Life’s Crucial 9: the role of proteomics and inflammation

Xiang H., Zhang Y., Zhang Y. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

Scientific Reports, 2025
Higher levels of plasma phosphatidylcholine (17:0_18:1) raise the risk of developing Parkinson’s disease

Su D., Jing Y., Su J. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Hematology, 2025
Exploring potential causal effects of circulating inflammatory proteins on hematologic malignancies and identifying cross-cancer drug targets: a Mendelian randomization study

Lu C., Wang M., Li J. et al.

Olink Target 96OncologyHematologyPathophysiologyPlasma

Discover Oncology, 2025
Two-sample Mendelian randomization analysis of the causal association between circulating inflammatory proteins and osteosarcoma

Tang H., Tang N., Liao Y. et al.

Olink Target 96OncologyPathophysiologyPlasma

Genes & Immunity, 2025
A multi-omics approach reveals dysregulated TNF-related signaling pathways in circulating NK and T cell subsets of young children with autism

Nour-Eldine W., Ltaief S., Ouararhni K. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Psychiatry Investigation, 2025
Cytokine-Related Genes and Inflammatory Profiles as Potential Biomarkers in Major Depressive Disorder

Oh H., Kong N., Jung S. et al.

Olink Target 96NeurologyPathophysiologyPatient StratificationPlasma

Aging Cell, 2025
Proteomic Signatures of Epigenetic Age in African Green Monkey Cerebrospinal Fluid and Plasma

Elsworth J., Neutzner A., Roux J. et al.

Olink Explore 3072/384AgingPathophysiologyMonkey PlasmaMonkey CSF

Cell Reports Medicine, 2025
A human milk oligosaccharide alters the microbiome, circulating hormones, and metabolites in a randomized controlled trial of older adults

Carter M., Demis D., Perelman D. et al.

Olink Target 96Nutritional ScienceAgingPathophysiologySerum

Clinical Research in Cardiology, 2025
Targeted proteomic profiling of transcatheter edge-to-edge repair failure in patients with mitral regurgitation and heart failure

Di Pasquale M., Ravassa S., Pagnesi M. et al.

Olink Target 96CVDPatient StratificationPlasma

Intensive Care Medicine, 2025
Identification of transcriptomic sepsis endotypes in sub-Saharan Africa: derivation, validation, and global alignment in two Ugandan cohorts

Cummings M., Lutwama J., Tomoiaga A. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma

Journal of Cancer, 2025
Comprehensive Mendelian randomization and colocalization analysis of plasma proteomics to identify new therapeutic targets for bladder cancer

Zuo J., Chen J., Tan Z. et al.

Olink Explore 3072/384OncologyPathophysiologyPlasma

Stem Cell Reviews and Reports, 2025
The Integration of Olink Proteomics with Transcriptomics Elucidates that TNF-α Induces Senescence and Apoptosis in Transplanted Mesenchymal Stem Cells

Zhou Y., Xiao J., Peng S. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyCell Culture Supernatant

Nature Genetics, 2025
Deciphering state-dependent immune features from multi-layer omics data at single-cell resolution

Edahiro R., Sato G., Naito T. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma

Nature Communications, 2025
Integrated multiomics of pressure overload in the human heart prioritizes targets relevant to heart failure

Lindman B., Perry A., Lance M. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

ESMO Open, 2025
Tislelizumab plus nab-paclitaxel and cisplatin as induction immunochemotherapy for organ preservation of locally advanced hypopharyngeal squamous cell carcinoma: a single-arm phase II trial

Gui L., Xie Z., Zhang W. et al.

Olink Target 96OncologyImmunotherapyPatient StratificationPlasma

Cancer Research, 2025
Dasatinib Remodels the Tumor Microenvironment and Sensitizes Small Cell Lung Cancer to Immunotherapy

Redin E., Otegui N., Santos M. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

Clinical Cancer Research, 2025
First-in-Human Phase 1/2 Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors

Hamid O., Cardin D., Hodi F. et al.

Olink Explore 3072/384OncologyImmunotherapyPathophysiologyPlasma

International Journal of Molecular Sciences, 2025
In-Depth Characterization of L1CAM+ Extracellular Vesicles as Potential Biomarkers for Anti-CD20 Therapy Response in Relapsing–Remitting Multiple Sclerosis

Anandan S., Maciak K., Breinbauer R. et al.

Olink FlexNeurologyPathophysiologySerumCSF

Alzheimer's & Dementia, 2025
Distinct inflammatory profiles in young‐onset versus late‐onset Alzheimer's disease

Thapa S., Anastassiadis C., Vasilevskaya A. et al.

Olink Explore 3072/384NeurologyPathophysiologyCSF

3269 publications